1 – 10 of 13
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Late Holocene peat paleodust deposition in south-western Sweden - exploring geochemical properties, local mineral sources and regional aeolian activity
(
- Contribution to journal › Article
- 2004
-
Mark
Skin toxicity as a risk factor for major infections in breast cancer patients treated with docetaxel
(
- Contribution to journal › Article
- 2003
-
Mark
Prognostic value of quality of life scores for time to progression (TTP) and overall survival time (OS) in advanced breast cancer
(
- Contribution to journal › Article
- 2002
-
Mark
Tumour microvessel density as predictor of chemotherapy response in breast cancer patients
(
- Contribution to journal › Article
-
Mark
The predictive value of bcl-2, bax, bcl-xL, bag-1, fas, and fasL for chemotherapy response in advanced breast cancer
(
- Contribution to journal › Article
-
Mark
C-erbB-2 expression does not predict response to docetaxel or sequential methotrexate and 5-fluorouracil in advanced breast cancer
(
- Contribution to journal › Article
-
Mark
Physical performance, toxicity, and quality of life as assessed by the physician and the patient
(
- Contribution to journal › Article
- 2001
-
Mark
Timing of quality of life (QoL) assessments as a source of error in oncological trials
(
- Contribution to journal › Article
- 2000
-
Mark
Newly diagnosed latent autoimmune diabetes in adults (LADA) is associated with low level glutamate decarboxylase (GAD65) and IA-2 autoantibodies
(
- Contribution to journal › Article
-
Mark
Quality of life in patients with metastatic breast cancer receiving either docetaxel or sequential methotrexate and 5-fluorouracil. A multicentre randomised phase III trial by the Scandinavian breast group
(
- Contribution to journal › Article